Your browser doesn't support javascript.
loading
Emergence and spread of a human-transmissible multidrug-resistant nontuberculous mycobacterium.
Bryant, Josephine M; Grogono, Dorothy M; Rodriguez-Rincon, Daniela; Everall, Isobel; Brown, Karen P; Moreno, Pablo; Verma, Deepshikha; Hill, Emily; Drijkoningen, Judith; Gilligan, Peter; Esther, Charles R; Noone, Peadar G; Giddings, Olivia; Bell, Scott C; Thomson, Rachel; Wainwright, Claire E; Coulter, Chris; Pandey, Sushil; Wood, Michelle E; Stockwell, Rebecca E; Ramsay, Kay A; Sherrard, Laura J; Kidd, Timothy J; Jabbour, Nassib; Johnson, Graham R; Knibbs, Luke D; Morawska, Lidia; Sly, Peter D; Jones, Andrew; Bilton, Diana; Laurenson, Ian; Ruddy, Michael; Bourke, Stephen; Bowler, Ian Cjw; Chapman, Stephen J; Clayton, Andrew; Cullen, Mairi; Daniels, Thomas; Dempsey, Owen; Denton, Miles; Desai, Maya; Drew, Richard J; Edenborough, Frank; Evans, Jason; Folb, Jonathan; Humphrey, Helen; Isalska, Barbara; Jensen-Fangel, Søren; Jönsson, Bodil; Jones, Andrew M.
Afiliação
  • Bryant JM; Wellcome Trust Sanger Institute, Hinxton, UK.
  • Grogono DM; University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, UK.
  • Rodriguez-Rincon D; University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, UK.
  • Everall I; Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, UK.
  • Brown KP; University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, UK.
  • Moreno P; Wellcome Trust Sanger Institute, Hinxton, UK.
  • Verma D; University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, UK.
  • Hill E; Cambridge Centre for Lung Infection, Papworth Hospital, Cambridge, UK.
  • Drijkoningen J; EMBL European Bioinformatics Institute, Hinxton, UK.
  • Gilligan P; Mycobacteria Research Laboratory, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins CO, USA.
  • Esther CR; Mycobacteria Research Laboratory, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins CO, USA.
  • Noone PG; University of Cambridge Department of Medicine, MRC-Laboratory of Molecular Biology, Cambridge, UK.
  • Giddings O; University of North Carolina School of Medicine, NC, USA.
  • Bell SC; University of North Carolina School of Medicine, NC, USA.
  • Thomson R; University of North Carolina School of Medicine, NC, USA.
  • Wainwright CE; University of North Carolina School of Medicine, NC, USA.
  • Coulter C; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Pandey S; School of Medicine, The University of Queensland, Australia.
  • Wood ME; The Prince Charles Hospital, Brisbane, Australia.
  • Stockwell RE; Gallipoli Medical Research Centre, University of Queensland, Brisbane, Australia.
  • Ramsay KA; School of Medicine, The University of Queensland, Australia.
  • Sherrard LJ; Lady Cilento Children's Hospital, Brisbane.
  • Kidd TJ; Queensland Mycobacterial Reference Laboratory, Brisbane, Australia.
  • Jabbour N; Queensland Mycobacterial Reference Laboratory, Brisbane, Australia.
  • Johnson GR; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Knibbs LD; School of Medicine, The University of Queensland, Australia.
  • Morawska L; The Prince Charles Hospital, Brisbane, Australia.
  • Sly PD; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Jones A; School of Medicine, The University of Queensland, Australia.
  • Bilton D; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Laurenson I; School of Medicine, The University of Queensland, Australia.
  • Ruddy M; QIMR Berghofer Medical Research Institute, Brisbane, Australia.
  • Bourke S; Centre for Experimental Medicine, Queen's University Belfast, UK.
  • Bowler IC; School of Chemistry and Biomolecular sciences, The University of Queensland, Australia.
  • Chapman SJ; Queensland University of Technology, Brisbane, Australia.
  • Clayton A; International Laboratory for Air Quality and Health, Queensland University of Technology, Brisbane, Australia.
  • Cullen M; International Laboratory for Air Quality and Health, Queensland University of Technology, Brisbane, Australia.
  • Daniels T; School of Public Health, The University of Queensland, Brisbane, Australia.
  • Dempsey O; International Laboratory for Air Quality and Health, Queensland University of Technology, Brisbane, Australia.
  • Denton M; Child Health Research Centre, The University of Queensland, Brisbane, Australia.
  • Desai M; Royal Brompton and Harefield NHS Foundation Trust, UK.
  • Drew RJ; Royal Brompton and Harefield NHS Foundation Trust, UK.
  • Edenborough F; Scottish Mycobacteria Reference Laboratory, UK.
  • Evans J; Wales Centre for Mycobacteria, UK.
  • Folb J; The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK.
  • Humphrey H; Oxford University Hospitals NHS Foundation Trust, UK.
  • Isalska B; Oxford University Hospitals NHS Foundation Trust, UK.
  • Jensen-Fangel S; Nottingham University Hospitals NHS Trust, UK.
  • Jönsson B; University Hospital of South Manchester NHS Foundation Trust, UK.
  • Jones AM; University Hospital of South Manchester NHS Foundation Trust, UK.
Science ; 354(6313): 751-757, 2016 11 11.
Article em En | MEDLINE | ID: mdl-27846606
ABSTRACT
Lung infections with Mycobacterium abscessus, a species of multidrug-resistant nontuberculous mycobacteria, are emerging as an important global threat to individuals with cystic fibrosis (CF), in whom M. abscessus accelerates inflammatory lung damage, leading to increased morbidity and mortality. Previously, M. abscessus was thought to be independently acquired by susceptible individuals from the environment. However, using whole-genome analysis of a global collection of clinical isolates, we show that the majority of M. abscessus infections are acquired through transmission, potentially via fomites and aerosols, of recently emerged dominant circulating clones that have spread globally. We demonstrate that these clones are associated with worse clinical outcomes, show increased virulence in cell-based and mouse infection models, and thus represent an urgent international infection challenge.
Assuntos

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Doenças Transmissíveis Emergentes / Fibrose Cística / Farmacorresistência Bacteriana Múltipla / Micobactérias não Tuberculosas / Infecções por Mycobacterium não Tuberculosas Tipo de estudo: Incidence_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Science Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Doenças Transmissíveis Emergentes / Fibrose Cística / Farmacorresistência Bacteriana Múltipla / Micobactérias não Tuberculosas / Infecções por Mycobacterium não Tuberculosas Tipo de estudo: Incidence_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Science Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido